Amicus Therapeutics Inc

NASDAQ:FOLD   3:59:53 PM EDT
12.00
-0.37 (-2.99%)
Earnings Announcements

Amicus Therapeutics Reports Q2 2022 Financial Results

Published: 08/04/2022 11:37 GMT
Amicus Therapeutics Inc (FOLD) - Amicus Therapeutics Announces Second Quarter 2022 Financial Results.
Q2 Loss per Share $0.21.
Q2 Revenue Rose 4 Percent to $80.7 Million.
For Full-year 2022, Company Anticipates Total Galafold Revenue of $350 Million to $365 Million.
Cash, Cash Equivalents, and Marketable Securities Totaled $386.8 Million at June 30, 2022.
Q2 Earnings per Share View $-0.22, Revenue View $85.9 Million -- Refinitiv Ibes Data (analyst estimates).
FY2022 Revenue View $355.0 Million -- Refinitiv Ibes Data (analyst estimates).
Revenue is expected to be $84.35 Million
Adjusted EPS is expected to be -$0.20

Next Quarter Revenue Guidance is expected to be $89.48 Million
Next Quarter EPS Guidance is expected to be -$0.18

More details on our Analysts Page.